%0 Journal Article
%A Casabonne, Delphine
%A Benavente, Yolanda
%A Seifert, Julia
%A Costas, Laura
%A Armesto, María
%A Arestin, María
%A Besson, Caroline
%A Saberi Hosnijeh, Fatemeh
%A Duell, Eric J
%A Weiderpass, Elisabete
%A Masala, Giovanna
%A Kaaks, Rudolf
%A Canzian, Federico
%A Chirlaque, María-Dolores
%A Perduca, Vittorio
%A Mancini, Francesca Romana
%A Pala, Valeria
%A Trichopoulou, Antonia
%A Karakatsani, Anna
%A La Vecchia, Carlo
%A Sánchez, Maria-Jose
%A Tumino, Rosario
%A Gunter, Marc J
%A Amiano, Pilar
%A Panico, Salvatore
%A Sacerdote, Carlotta
%A Schmidt, Julie A
%A Boeing, Heiner
%A Schulze, Matthias B
%A Barricarte, Aurelio
%A Riboli, Elio
%A Olsen, Anja
%A Tjønneland, Anne
%A Vermeulen, Roel
%A Nieters, Alexandra
%A Lawrie, Charles H
%A de Sanjosé, Silvia
%T Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
%J International journal of cancer
%V 147
%N 5
%@ 1097-0215
%C Bognor Regis
%I Wiley-Liss
%M DKFZ-2020-00333
%P 1315-1324
%D 2020
%Z 2020 Sep 1;147(5):1315-1324
%X Serum levels of hsa-miR-16-5p, -29a-3p, -150-5p, -155-5p and -223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:32012253
%R 10.1002/ijc.32894
%U https://inrepo02.dkfz.de/record/153589